Shah Wealth Advisors LLC purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 85,476 shares of the exchange traded fund’s stock, valued at approximately $13,478,000. SPDR S&P Biotech ETF accounts for 2.7% of Shah Wealth Advisors LLC’s holdings, making the stock its 14th largest position. Shah Wealth Advisors LLC owned approximately 0.13% of SPDR S&P Biotech ETF at the end of the most recent quarter.
A number of other large investors have also made changes to their positions in the company. Bank of America Corp DE raised its stake in SPDR S&P Biotech ETF by 13.3% during the 1st quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after buying an additional 1,700,851 shares during the period. Moss Adams Wealth Advisors LLC acquired a new position in SPDR S&P Biotech ETF in the third quarter valued at about $30,841,000. Northwestern Mutual Wealth Management Co. grew its stake in SPDR S&P Biotech ETF by 145.7% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 314,224 shares of the exchange traded fund’s stock valued at $49,726,000 after acquiring an additional 186,314 shares during the period. Parkway Wealth Management Group LLC acquired a new position in SPDR S&P Biotech ETF in the third quarter valued at about $26,452,000. Finally, Wellington Management Group LLP acquired a new position in SPDR S&P Biotech ETF in the second quarter valued at about $19,270,000.
SPDR S&P Biotech ETF Price Performance
Shares of SPDR S&P Biotech ETF stock opened at $150.55 on Monday. SPDR S&P Biotech ETF has a 1 year low of $111.11 and a 1 year high of $169.89. The business has a 50-day moving average of $154.26 and a two-hundred day moving average of $142.92. The company has a market capitalization of $10.20 billion, a P/E ratio of 20.64 and a beta of 0.87.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Recommended Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- 3 Large-Cap Stocks Are Outperforming the S&P 500 Without AI Hype
- Fossil Just Turned a Profit—Can Its Comeback Survive the Holidays?
- Beaming Up the Backlog: AeroVironment Lands $405M Laser Deal
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
